UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Molecular therapy, 2017-12, Vol.25 (12), p.2620-2634

2017

Volltextzugriff (PDF)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity

Viruses, 2017-12, Vol.9 (12), p.382

2017

Volltextzugriff (PDF)

Oncolytic parvoviruses: from basic virology to clinical applications

Virology journal, 2015-01, Vol.12 (1), p.6-6, Article 6

2015

Volltextzugriff (PDF)

Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study

Frontiers in immunology, 2019-08, Vol.10, p.1848-1848

2019

Volltextzugriff (PDF)

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses

Viruses, 2019-05, Vol.11 (5), p.415

2019

Volltextzugriff (PDF)

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Clinical cancer research, 2021-10, Vol.27 (20), p.5546-5556

2021

Volltextzugriff (PDF)

Fluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors

Methods in molecular biology (Clifton, N.J.), 2020-01, Vol.2058, p.295

2020

Volltextzugriff (PDF)

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer

Journal of virology, 2014-05, Vol.88 (10), p.5263-5276

2014

Volltextzugriff (PDF)

The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics

Pathogens (Basel), 2024-02, Vol.13 (3), p.184

2024

Volltextzugriff (PDF)

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers

Cancers, 2021-01, Vol.13 (2), p.342

2021

Volltextzugriff (PDF)

H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma

Cancers, 2024-08, Vol.16 (15), p.2711

2024

Volltextzugriff (PDF)

Oncolytic parvoviruses as cancer therapeutics

Cytokine & growth factor reviews, 2010-04, Vol.21 (2), p.185-195

2010

Volltextzugriff (PDF)

The Promise of Gene Therapy for Pancreatic Cancer

Human gene therapy, 2016-02, Vol.27 (2), p.127-133

2016

Volltextzugriff (PDF)

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers

Frontiers in oncology, 2017-05, Vol.7, p.93-93

2017

Volltextzugriff (PDF)

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

Clinical cancer research, 2009-01, Vol.15 (2), p.511-519

2009

Volltextzugriff (PDF)

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

BMC cancer, 2017-08, Vol.17 (1), p.576-576, Article 576

2017

Volltextzugriff (PDF)

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients

Frontiers in bioengineering and biotechnology, 2015-01, Vol.3, p.55-55

2015

Volltextzugriff (PDF)

Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Pancreas, 2016-11, Vol.45 (10), p.1452-1460

2016

Volltextzugriff (PDF)

Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation

Amino acids, 2018-08, Vol.50 (8), p.1131-1143

2018

Volltextzugriff (PDF)

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells

Pathogens (Basel), 2023-04, Vol.12 (4), p.607

2023

Volltextzugriff (PDF)

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections

Pathogens (Basel), 2022-02, Vol.11 (2), p.208

2022

Volltextzugriff (PDF)

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

Molecular therapy, 2009-07, Vol.17 (7), p.1164-1172

2009

Volltextzugriff (PDF)

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

Cancer biology & therapy, 2011-11, Vol.12 (10), p.888-895

2011

Volltextzugriff (PDF)

Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells

Journal of Oncology, 2011-01, Vol.2011 (2011), p.222-226

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity

Oncolytic parvoviruses: from basic virology to clinical applications

Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Fluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer

The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers

H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma

Oncolytic parvoviruses as cancer therapeutics

The Promise of Gene Therapy for Pancreatic Cancer

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients

Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells

Suchergebnisse filtern